Rossari Biotech Share Price Target 2026 — Analyst Forecast, Catalysts and Key Risks

Thu Apr 23 2026

The Rossari Biotech share price target 2026 stands at Rs 827-947 as per analyst consensus — implying 20-38% upside from the current CMP of Rs 687. Investors tracking the Rossari Biotech share price target 2026 need to understand the complete picture — the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Rossari Biotech (ROSSARI) achieves or misses this 12-month target. This article covers every dimension of the Rossari Biotech share price target 2026 thesis — catalysts, risks, scenarios, analyst ratings, and key levels — updated April 2026.

Click Here — Get Free SEBI-registered Research on Rossari Biotech on Univest.

Table of Contents

Rossari Biotech Share Price Overview — April 2026

Company	Rossari Biotech
NSE Symbol	ROSSARI
Sector	Specialty Chemicals / Home Care / Textile Auxiliaries
CMP April 2026	Rs 687
52-Week High	Rs 987
52-Week Low	Rs 547
Market Cap	Rs 3,660 Cr
Trailing P/E	28x
Dividend FY26	Rs 3
Promoter Holding	62.4%
FII Holding	12.8%
12M Analyst Target	Rs 827-947
Upside from CMP	20-38%

Data from NSE/BSE and publicly available research. April 2026. Verify before investing.

Track live Rossari Biotech price, FII/DII flows and analyst targets on the Univest Screener.

What Is Rossari Biotech?

Get Free Analyst Research on Rossari Biotech — Tap Here.

Rossari Biotech (NSE: ROSSARI) manufactures home care chemicals, textile auxiliaries, and animal nutrition ingredients. FY26 revenue Rs 1,200+ crore growing 15%+. Dahej capacity expansion completed.

Budget 2026-27 Impact on Specialty Chemicals

Budget 2026-27’s textile PLI, FMCG growth, and animal husbandry support create demand tailwinds for Rossari’s three core chemical end-markets.

Rossari Biotech share price target 2026 — Short, 12-Month and Long-Term Horizons

Horizon	Target	Key Assumption
Short-Term 3-6 Months	Rs 827	Q4 FY26 results beat and technical recovery
12-Month Consensus	Rs 827-947	FY27 earnings delivery and macro normalisation
Long-Term FY27-28	20-30% above 12M	Full earnings recovery and sector re-rating
Bear Case	Rs 547 zone	FY27 miss and extended FII selling

Compare Rossari Biotech with sector peers live on the Univest Screener.

5 Growth Catalysts Supporting the Rossari Biotech share price target 2026

1. India Specialty Chemicals Sector — Structural Growth Tailwind

India’s Specialty Chemicals sector is expanding at 12-18% annually — driven by rising incomes, urbanisation, government policy, and the India structural growth story. Rossari Biotech’s market position within this sector creates compounding runway that underpins the Rossari Biotech share price target 2026 consensus of Rs 827-947. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.

2. FY27 Earnings Recovery — Primary Re-Rating Catalyst

After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Rossari Biotech to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the Rossari Biotech share price target 2026 consensus of Rs 827-947. Track Q4 results live on the Univest Screener.

3. Competitive Moat — Defensible Market Position Built Over Decades

Rossari Biotech holds a structural competitive moat in its Specialty Chemicals segment — brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles — the structural argument for the premium valuation embedded in the Rossari Biotech share price target 2026 of Rs 827-947.

4. RBI Rate Cut Cycle — Reducing Cost of Capital

India’s RBI rate cut cycle commenced in 2026 reduces Rossari Biotech’s borrowing costs and stimulates end-customer demand for Specialty Chemicals products. Lower interest rates improve EBITDA-to-PAT conversion — directly expanding EPS and supporting the Rossari Biotech share price target 2026 of Rs 827-947 by making the earnings multiple more justifiable.

5. Budget 2026-27 Policy Alignment and Government Capex Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Rossari Biotech’s Specialty Chemicals business. Regulatory clarity and government spending certainty reduce operating risk — improving earnings visibility that directly supports the Rossari Biotech share price target 2026 bull case.

Download the Univest iOS App or Android App for live Rossari Biotech alerts and SEBI-registered research.

5 Risks That Could Impact the Rossari Biotech share price target 2026

1. US Tariff and Global Macro Headwinds

The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Rossari Biotech. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% — the key downside risk to the Rossari Biotech share price target 2026 consensus of Rs 827-947.

2. Valuation at 28x Requires Consistent Execution

At 28x trailing P/E, Rossari Biotech is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression — the most immediate risk to the Rossari Biotech share price target 2026. The Rs 547 52-week low zone is the key support and stop-loss reference.

3. Competition Intensifying in Specialty Chemicals

Domestic and global competitors are investing aggressively in Rossari Biotech’s Specialty Chemicals market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the Rossari Biotech share price target 2026.

4. Input Cost and Supply Chain Volatility

Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates — creating downside risk to the Rossari Biotech share price target 2026 of Rs 827-947.

5. FII Selling Risk — 12.8% Institutional Holding

With 12.8% FII ownership, Rossari Biotech is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the Rossari Biotech share price target 2026 analyst consensus of Rs 827-947.

Rossari Biotech Bull Case vs Bear Case — Rossari Biotech share price target 2026

Scenario	Price Target	Probability	Trigger
Bull Case	947	Medium	FY27 earnings beat, FII re-entry, sector re-rating
Base Case	Rs 827-947	High	FY27 in-line earnings, stable macro
Bear Case	Rs 547 zone	Low	FY27 guidance cut, prolonged FII selling

Rossari Biotech Share Price Reference Table

NSE Symbol	ROSSARI
CMP	Rs 687
52-Week High	Rs 987
52-Week Low	Rs 547
Market Cap	Rs 3,660 Cr
P/E	28x
Promoter	62.4%
FII	12.8%
Dividend FY26	Rs 3
Short-Term Target	Rs 827
12M Target	Rs 827-947
Upside	20-38%

Sources: NSE/BSE, Screener.in, publicly available analyst research. April 2026.

Analyst Ratings and Rossari Biotech share price target 2026

Brokerage	Rating	Target	Key View
MOFSL	Buy	Rs 824	FY27 earnings recovery and Specialty Chemicals sector leadership
YES Securities	Buy	Rs 838	Quality execution — accumulate at support levels
Kotak Institutional	Add	Rs 790	Monitor Q4 FY26 guidance — maintain position
JM Financial	Neutral	Consensus	Await Q4 FY26 result clarity before adding

Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Rossari Biotech.

How to Invest in Rossari Biotech — 5 Steps

Step 1: Research on the Univest Screener

Search ROSSARI on univest.in/screeners. Review quarterly results, FII/DII trend, promoter holding, and analyst consensus on the Rossari Biotech share price target 2026.

Step 2: Identify Entry Level

Rossari Biotech at Rs 687 has key support near Rs 547. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the Rossari Biotech share price target 2026 recovery is Rs 827.

Step 3: Monitor Q4 FY26 Results

Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 947 — the bull case for the Rossari Biotech share price target 2026.

Step 4: Position Sizing

Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.

Step 5: Track on the Univest App

Download the Univest iOS App or Android App for live price alerts and SEBI-registered research aligned with the Rossari Biotech share price target 2026.

Conclusion — Rossari Biotech share price target 2026

Rossari Biotech (ROSSARI) at Rs 687 offers 20-38% potential upside to the 12-month Rossari Biotech share price target 2026 consensus of Rs 827-947. The bull case to 947 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 547 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Rossari Biotech at current levels presents a monitored entry opportunity. For more Rossari Biotech share price target 2026 analysis and peer comparisons, visit Univest Blogs.

Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions — Rossari Biotech share price target 2026

Q: What is Rossari Biotech share price target for 2026?

The 12-month Rossari Biotech share price target 2026 analyst consensus is Rs 827-947 — implying 20-38% upside from CMP Rs 687. Bull case: 947. Bear case: Rs 547 zone. Track the live Rossari Biotech share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.

Q: Is Rossari Biotech a good buy at Rs 687?

This article does not constitute investment advice. At Rs 687, Rossari Biotech offers 20-38% upside to the Rossari Biotech share price target 2026 consensus of Rs 827-947. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.

Q: What is Rossari Biotech 52-week high and low?

Rossari Biotech’s 52-week high is Rs 987 and 52-week low is Rs 547. At the current CMP of Rs 687, the stock has corrected from its 52-week high — creating recovery potential for investors aligned with the Rossari Biotech share price target 2026 thesis.

Q: What sector is Rossari Biotech (ROSSARI) in?

Rossari Biotech operates in the Specialty Chemicals / Home Care / Textile Auxiliaries sector. India’s Specialty Chemicals sector is growing structurally — driven by rising incomes, government policy, and India’s consumption expansion — underpinning the Rossari Biotech share price target 2026 bull case.

Q: What are the main risks for the Rossari Biotech share price target 2026 thesis?

Key risks: US tariff macro headwinds, valuation at 28x requiring consistent execution, competition in Specialty Chemicals, input cost volatility, and FII selling pressure (12.8% holding). Monitor quarterly earnings closely.

Q: What is Rossari Biotech’s market cap?

Rossari Biotech has a market cap of Rs 3,660 Cr as of April 2026. At the Rossari Biotech share price target 2026 of Rs 827-947, the implied market cap would reflect 20-38% appreciation on the current base.

Q: What is Rossari Biotech dividend for FY26?

Rossari Biotech’s FY26 dividend is Rs 3. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the Rossari Biotech share price target 2026 capital appreciation potential.

Q: How to buy Rossari Biotech shares?

Buy Rossari Biotech (ROSSARI) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 547 support zone, and download the Univest App for SEBI-registered research on the Rossari Biotech share price target 2026.